U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

1954
119
Name Type Language
BARSTATIN 100
Preferred Name English
NYSTATIN
EP   GREEN BOOK   HSDB   INN   MI   ORANGE BOOK   USP   USP-RS   VANDF   WHO-DD   WHO-IP  
INN  
Official Name English
NYSTATIN [MI]
Common Name English
NYSTATIN [USP MONOGRAPH]
Common Name English
NYSTAFORM COMPONENT NYSTATIN
Common Name English
MYCOSTATIN
Brand Name English
TERRASTATIN
Common Name English
MYKINAC
Brand Name English
NYSTEX
Brand Name English
KOROSTATIN
Brand Name English
MYTREX F COMPONENT NYSTATIN
Common Name English
MIKOSTATIN
Brand Name English
L-NYSTATIN
Common Name English
MYCOLOG COMPONENT NYSTATIN
Brand Name English
NYSTATIN [EP MONOGRAPH]
Common Name English
NYSTATIN [JAN]
Common Name English
NYSTATIN [WHO-IP]
Common Name English
NYSTATIN [EP IMPURITY]
Common Name English
NYSTOP
Brand Name English
NYSTATIN [GREEN BOOK]
Common Name English
NSC-150817
Code English
NYSTATIN [ORANGE BOOK]
Common Name English
NILSTAT
Brand Name English
CANDEX
Brand Name English
NYSTATIN [HSDB]
Common Name English
NYSTATIN [VANDF]
Common Name English
NYSTATINUM [WHO-IP LATIN]
Common Name English
nystatin [INN]
Common Name English
MYKACET COMPONENT NYSTATIN
Common Name English
NYSTATIN [USP-RS]
Common Name English
Nystatin [WHO-DD]
Common Name English
Classification Tree Code System Code
NDF-RT N0000007672
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
WHO-ATC A07AA02
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
WHO-VATC QG01AA01
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
NCI_THESAURUS C514
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
WHO-ESSENTIAL MEDICINES LIST 6.3
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
CFR 21 CFR 524.1600A
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
CFR 21 CFR 524.1600
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
CFR 21 CFR 524.1600B
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
WHO-ATC G01AA51
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
FDA ORPHAN DRUG 133800
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
WHO-VATC QG01AA51
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
NDF-RT N0000175498
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
LIVERTOX NBK548581
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
WHO-ATC D01AA01
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
CFR 21 CFR 556.470
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
WHO-ATC G01AA01
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
CFR 21 CFR 558.430
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
WHO-VATC QD01AA01
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
WHO-VATC QA07AA02
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
Code System Code Type Description
DAILYMED
BDF1O1C72E
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
RXCUI
7597
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY RxNorm
WHO INTERNATIONAL PHARMACOPEIA
NYSTATIN
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY Description: A yellow to light brown powder.Solubility: Very slightly soluble in water; sparingly soluble in ethanol (~750 g/l) TS and methanol R; practically insoluble in ether R. Category: Antifungal drug. Storage: Nystatin should be kept in a tightly closed container, protected from light and stored at a temperature not exceeding 5?C. Additional information: Nystatin is hygroscopic. Even in the absence of light, it is gradually degraded on exposure to a humidatmosphere, the decomposition being faster at higher temperatures. The potency of Nystatin may fall at a rate of 1% per monthwhen it is stored under the conditions mentioned above. Definition: Nystatin is a mixture of substances produced by the growth of certain strains of Streptomyces noursei, the maincomponent of which is nystatin A1. Nystatin contains not less than 4400 International Units per mg, calculated with reference to the dried substance.
CAS
1400-61-9
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
MESH
D009761
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
MERCK INDEX
m8095
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY Merck Index
INN
539
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
NSC
150817
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
HSDB
3138
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
NCI_THESAURUS
C710
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
SMS_ID
100000089986
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
LACTMED
Nystatin
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
CHEBI
7660
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
FDA UNII
BDF1O1C72E
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
WIKIPEDIA
NYSTATIN
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
RS_ITEM_NUM
1477003
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
EVMPD
SUB03475MIG
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
DRUG BANK
DB00646
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
ECHA (EC/EINECS)
215-749-0
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
EPA CompTox
DTXSID4040688
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
DRUG CENTRAL
1977
Created by admin on Mon Mar 31 18:08:12 GMT 2025 , Edited by admin on Mon Mar 31 18:08:12 GMT 2025
PRIMARY
All of the following components must be present:
Structure of NYSTATIN A1
Structure of NYSTATIN A3
Structure of NYSTATIN A2
ACTIVE MOIETY
NYSTATIN
Definition References
NIH
NCATS
PRIVACY NOTICE
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966